October 25, 2019
Vistin Pharma ends Q3 2019 with revenue up 31%, and goes to net gain vs loss in Q3 2018
Vistin Pharma posted net financial gain for the third quarter NOK 68.1 million (€6.68M), compared to a net loss of NOK 4.3 million in the same period last year, resulting with the net financial gain for the quarter primarily relates to an unrealised gain on oil derivatives of NOK 66.7 million.
